ReviewBiomimetics (Basel, Switzerland)2025
Machine Learning-Driven Prediction of Reactive Oxygen Species Dynamics for Assessing Nanomaterials' Cytotoxicity.
Review in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Advanced nanocatalytic medicine for genitourinary diseases: Reactive oxygen modulation, precision therapeutics, and clinical translation.Materials today. Bio · 2026Article
- Review
- Titanium Dioxide Nanoparticle-Driven Metabolic and Molecular Reprogramming in Cyanobacteria.Molecules (Basel, Switzerland) · 2026Review
- Redox-modulating metallic nanoparticles: mechanistic insights into pharmacological activity and cellular therapeutics.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Interpretable Small-Sample Deep Learning with Approximate Attribution Enhancement for Atomically Precise Gold Nanoclusters Synthesis.Molecules (Basel, Switzerland) · 2026Article
- The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications.Journal of hematology & oncology · 2026Review
- Panoramic description of ROS-based nanotechnology for osteomyelitis therapy: Challenges, opportunities, and prospects.Theranostics · 2026Review
- Artificial intelligence-assisted photodynamic diagnosis and photodynamic therapy against cancer.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanomaterials (NMs) possess unique physicochemical features that set them apart from bulk counterparts. Their adjustable properties provide remarkable flexibility, giving rise to a wide array of variants. However, these attributes can also trigger complex biological interactions, particularly the generation of reactive oxygen species (ROS), which are central to nanomaterial-induced cytotoxicity. The ambivalent nature of ROS, essential for physiological signaling yet harmful when dysregulated, can lead to substantial health consequences. The scarcity of reliable toxicity and safety data, together with the inadequacies of conventional testing methods, highlights the urgent need for more effective strategies to assess nanomaterial-related hazards and risks. Given the intricate interplay between NMs and biological systems, computational approaches, particularly machine learning (ML), have emerged as powerful tools to model ROS dynamics, predict cytotoxic outcomes, and optimize nanomaterial design. This review highlights recent advances in applying ML to predict both the generation and neutralization of ROS by diverse NMs and to identify the critical determinants underlying ROS-mediated toxicity. These insights provide new opportunities for predictive nanotoxicology and the development of safer, application-tailored NMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.